| 2BXC | A:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE |
| 2BXD | A:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN |
| 2BXI | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE |
| 2BXK | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, AZAPROPAZONE AND INDOMETHACIN |
| 2BXQ | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, PHENYLBUTAZONE AND INDOMETHACIN |
| 2VDB | A:197-388; A:389-584; A:6-196 | STRUCTURE OF HUMAN SERUM ALBUMIN WITH S-NAPROXEN AND THE GA MODULE |
| 2VUF | A:5-196; A:197-388; A:389-570; B:5-196; B:197-388; B:389-562 | HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID |
| 2XSI | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-GLUTAMATE AND MYRISTIC ACID |
| 2XVV | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE AND MYRISTIC ACID |
| 2XVW | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ARGININE AND MYRISTIC ACID |
| 3CX9 | A:3-196; A:197-388; A:389-584 | CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND LYSOPHOSPHATIDYLETHANOLAMINE |
| 3SQJ | A:3-196; A:197-388; A:389-584; B:3-196; B:197-388; B:389-584 | RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC PLANT |
| 4BKE | A:3-196; A:197-388; A:389-584 | RECOMBINANT HUMAN SERUM ALBUMIN WITH PALMITIC ACID. SYNTHETIC CATIONIC ANTIMICROBIAL PEPTIDES BIND WITH THEIR HYDROPHOBIC PARTS TO DRUG SITE II OF HUMAN SERUM ALBUMIN |
| 4HGK | A:4-196; A:197-388; B:4-196; B:197-388 | SHARK IGNAR VARIABLE DOMAIN |
| 4N0F | D:3-196; D:197-388; D:389-585; G:3-196; G:197-388; G:389-585; J:3-196; J:197-388; J:389-585; M:3-196; M:197-388; M:389-585 | HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN |
)
)